BeOne Medicines (BEIGF) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2025)
BeOne Medicines (BEIGF) EPS (Weighted Average and Diluted) Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
251.11% |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
-13.31% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
102.51% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
-103.05% |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
61.45% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
136.36% |
| Sep 30, 2025 |
188.89% |
| Jun 30, 2025 |
166.67% |
| Dec 31, 2024 |
59.26% |
| Sep 30, 2024 |
-160.00% |
| Jun 30, 2024 |
67.86% |
| Mar 31, 2024 |
26.92% |
| Dec 31, 2023 |
18.18% |
| Sep 30, 2023 |
136.59% |
| Jun 30, 2023 |
33.33% |
| Mar 31, 2023 |
21.21% |
| Dec 31, 2022 |
32.65% |
| Sep 30, 2022 |
-13.89% |
| Jun 30, 2022 |
-5.00% |
| Mar 31, 2022 |
-760.00% |
| Mar 31, 2021 |
113.89% |
| Sep 30, 2018 |
-195.00% |
| Sep 30, 2017 |
350.00% |
